Treatment with topical tacrolimus favors chronic actinic dermatitis: A clinical and immunopathological study

Journal of Dermatological Treatment

Volumn 21, Issue 3, 2010, Pages 171-177

  Ma, Ying ^a   Lu, Zhong ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Langerhans' cells; Photosensitivity disorders; Tacrolimus

Indexed keywords

CD11B ANTIGEN; CHEMOKINE RECEPTOR CCR7; T6 ANTIGEN; TACROLIMUS;

ADULT; ARTICLE; CHRONIC ACTINIC DERMATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DERMATITIS; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; SKIN BIOPSY; TREATMENT RESPONSE;

ADMINISTRATION, TOPICAL; ADULT; ANTIBODIES, MONOCLONAL; BIOPSY, NEEDLE; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; OINTMENTS; PHOTOSENSITIVITY DISORDERS; RECEPTORS, CHEMOKINE; RISK ASSESSMENT; SKIN ABSORPTION; TACROLIMUS; TREATMENT OUTCOME;

EID: 77951132331     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.3109/09546630903575547     Document Type: Article

References (19)

1. Hanifin JM, Thurston M, Omoto M, Cherill R, Tofte SJ, Graeber M. The eczema area and severity index (EASI): Assessment of reliability in atopic dermatitis. EASI Evaluator Group. Exp Dermatol. 2001;10(1):11-18.
2. Lim HW. Chronic actinic dermatitis. Dermatology at the millennium. 1999;664-665.
3. Hawk JLM, Magnus IA. Chronic actinic dermatitis-an idiopathic photosensitivity syndrome including actinic reticuloid and photosensitive eczema. Br J Dermatol. 1979;101:24.
4. Manage HD, Sattar N, Hawk JLM. Immunophenotyping of the inflammatory cell infiltrate during the evolution of induced lesions of chronic actinic dermatitis. J Invest Dermatol. 1993;100(4):482.
5. Novak N, Bieber T. The role of dendritic cells in atopic dermatitis. Clin Exp Allergy Rev. 2004;4:140-145. (Pubitemid 40095168)
6. Wollenberg A, Kraft S, Hanau D, Bieber T. Immunomorphological and ultrastructural characterization of Langerhans cells and a novel, inflammatory dendritic epidermal cell (IDEC) population in lesional skin of atopic eczema. J Invest Dermatol. 1996;106(3):446-453.
7. Ruzicka T, Bieber T, Schopf E, Rubins A, Dobozy A, Bos JD, et al. A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group. N Engl J Med. 1997;337(12):816-821.
8. Dumont FJ. FK506, an immunosuppressant targeting calcineurin function. Curr Med Chem. 2000;7(7):731-748.
9. Wollenberg A, Sharma S, von Bubnoff D, Geiger E, Haberstok J, Bieber T. Topical tacrolimus (FK506) leads to profound phenotypic and functional alterations of epidermal antigen-presenting dendritic cells in atopic dermatitis. J Allergy Clin Immunol. 2001;107(3):519-525.
10. Inoue T, Katoh N, Kishimoto S. Prolonged topical application of tacrolimus inhibits immediate hypersensitivity reactions by reducing degranulation of mast cells. Acta Derm Venereol. 2006;86(1):13-16.
11. Uetsu N, Okamoto H, Fujii K, Doi R, Horio T. Treatment of chronic actinic dermatitis with tacrolimus ointment. J Am Acad Dermatol. 2002;47(6):881-884. (Pubitemid 35403047)
12. Evans AV, Palmer RA, Hawk JL. Erythrodermic chronic actinic dermatitis responding only to topical tacrolimus. Photodermatol Photoimmunol Photomed. 2004;20(1):59-61.
13. Schuster C, Zepter K, Kempf W, Dummer R. Successful treatment of recalcitrant chronic actinic dermatitis with tacrolimus. Dermatology. 2004;209(4):325-328.
14. Carroll CL, Fleischer AB Jr. Tacrolimus ointment: The treatment of atopic dermatitis and other inflammatory cutaneous disease. Expert Opin Pharmacother. 2004;5(10): 2127-2137.
15. Bieber T, Dannenberg B, Prinz JC, Rieber EP, Stolz W, Braun-Falco O, et al. Occurrence of IgE-bearing epidermal Langerhans cells in atopic eczema: A study of the time course of the lesions and with regard to the IgE serum level. J Invest Dermatol. 1989;93(2):215-219.
16. Panhans-Gross A, Novak N, Kraft S, Bieber T. Human epidermal Langerhans' cells are targets for the immunosuppressive macrolide tacrolimus (FK506). J Allergy Clin Immunol. 2001;107(2):345-352.
17. Gunn MD, Kyuwa S, Tam C, Kakiuchi T, Matsuzawa A, Williams LT, et al. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J Exp Med. 1999; 189(3):451-460.
18. Sozzani S, Allavena P, D'Amico G, Luini W, Bianchi G, Kataura M, et al. Differential regulation of chemokine receptors during dendritic cell maturation: A model for their trafficking properties. J Immunol. 1998;161(3): 1083-1086.
19. Cyster JG. Chemokines and the homing of dendritic cells to the T cell areas of lymphoid organs. J Exp Med. 1999;189(3): 447-450.